Amova Asset Management Americas, Inc.
Position in GENB — Generate Biomedicines, Inc.
CIK 1480751
NEW YORK, NY
Position in GENB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$644,737
+$140,437 QoQ
Shares Held
38,218
-5.3% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 85 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GENB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amova Asset Management Americas, Inc. holds $354,236,903 across 20 Biotechnology names. GENB ranks #15 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BEAM |
Beam Therapeutics Inc.
|
3,455,043 | $118,577,075 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
1,720,097 | $93,814,090 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
2,897,529 | $49,026,190 | |
| 4 | NRIX |
Nurix Therapeutics, Inc.
|
983,462 | $23,858,788 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
5,511,687 | $20,227,891 | |
| 6 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
1,960,458 | $13,174,277 | |
| 7 | ABSI |
Absci Corp
|
1,013,965 | $11,751,854 | |
| 8 | PRME |
Prime Medicine, Inc.
|
2,407,018 | $8,881,896 |
All Filings in GENB
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $644,737 | 38,218 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $504,300 | 40,344 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||